Topbuild Corp buy BiotechBee
Start price
08.08.23
/
70%
€268.00
Target price
31.01.26
€330.00
Performance (%)
-12.69%
End price
01.10.23
€234.00
Summary
This prediction ended on 01.10.23 with a price of €234.00. The price of Topbuild Corp has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.69%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Topbuild Corp | 3.653% | 3.653% | 44.586% |
| iShares Core DAX® | 0,46 % | -2,00 % | 9,98 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % | -0,78 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % | 28,82 % |
| iShares S&P 500 | -1,76 % | -3,67 % | -0,54 % |
According to BiotechBee what are the pros and cons of Topbuild Corp for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Topbuild Corp diskutieren
Buy mit Kursziel 330,0